APA (7th ed.) Citation

Adhikari, H., Kattan, W. E., Kumar, S., Zhou, P., Hancock, J. F., & Counter, C. M. (2021). Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity. Nature Portfolio.

Chicago Style (17th ed.) Citation

Adhikari, Hema, Walaa E. Kattan, Shivesh Kumar, Pei Zhou, John F. Hancock, and Christopher M. Counter. Oncogenic KRAS Is Dependent upon an EFR3A-PI4KA Signaling Axis for Potent Tumorigenic Activity. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Adhikari, Hema, et al. Oncogenic KRAS Is Dependent upon an EFR3A-PI4KA Signaling Axis for Potent Tumorigenic Activity. Nature Portfolio, 2021.